NCT06130150

Brief Summary

Our aim with this study is to evaluate the sexual functions of pregnant women whose pregnancies are defined as high-risk pregnancies and whose pregnancies are followed by perinatology specialists.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
400

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jul 2021

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 10, 2021

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 10, 2022

Completed
1.8 years until next milestone

First Submitted

Initial submission to the registry

November 8, 2023

Completed
6 days until next milestone

First Posted

Study publicly available on registry

November 14, 2023

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2024

Completed
Last Updated

November 14, 2023

Status Verified

November 1, 2023

Enrollment Period

6 months

First QC Date

November 8, 2023

Last Update Submit

November 8, 2023

Conditions

High Risk PregnancySexual DysfunctionAnxietyFemale Sexual Function

Keywords

high-risk pregnancyperinatologysexual dysfunctionfemale sexual functionfsfi

Outcome Measures

Primary Outcomes (1)

  • 1

    High-risk pregnant women have lower FSFI score results then normal pregnant women

    1 day

Study Arms (2)

High-risk

This group includes pregnant women with the risk factors determined in the study

Normal

This group includes pregnant women with no risk

Eligibility Criteria

Age18 Years - 40 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

Pregnant women between the ages of 18-40 who were diagnosed with risky pregnancy for any reason during their pregnancy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Prof. Dr. Cemil Tascioglu City Hospital

Istanbul, Sisli, 34384, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Sexual Dysfunction, PhysiologicalAnxiety Disorders

Condition Hierarchy (Ancestors)

Genital DiseasesUrogenital DiseasesMental Disorders

Central Study Contacts

Cagdas Nurettin Emeklioglu, MD

CONTACT

+905359129913c.n.emeklioglu@gmail.com

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Target Duration
1 Day
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

November 8, 2023

First Posted

November 14, 2023

Study Start

July 10, 2021

Primary Completion

January 10, 2022

Study Completion

January 1, 2024

Last Updated

November 14, 2023

Record last verified: 2023-11

Locations

TU(1)